Hans-Peter Hasler

Hans-Peter Hasler

Chairman bij SHIELD THERAPEUTICS PLC

Vermogen: 2 M $ op 31-03-2024

68 jaar
Health Technology
Commercial Services
Finance

Profiel

Hans-Peter Hasler is the founder of Vicarius Pharma AG, which was founded in 2016.
He is currently the Chairman of HBM Healthcare Investments AG since 2009, the Non-Executive Chairman of Shield Therapeutics Plc since 2018, the Chairman of Medical Imaging Analysis Center since 2012, an Independent Director of Minerva Neurosciences, Inc. since 2017, an Independent Director of Gain Therapeutics, Inc. since 2021, and a Principal at Hph Management GmbH.
Mr. Hasler's former positions include Vice Chairman of Santhera Pharmaceuticals Holding AG from 2006 to 2011, Director of Acino International AG from 2008 to 2013, Independent Non-Executive Director of Dr. Reddy's Laboratories Ltd.
from 2016 to 2018, Managing Director of Wyeth Pharma GmbH, Director of Ferring Holding SA, Director of Ferring International Center SA, Independent Director of Celltrion, Inc., Managing Director of Wyeth Pharmaceuticals AG from 1993 to 1998, Director of Canyon Pharmaceuticals AG, Director of Aop Orphan Pharmaceuticals GmbH, Managing Director of Wyeth-lederle Pharma GmbH, Director of Dr. Reddy's Laboratories SA, Independent Non-Executive Director of Patheon NV from 2016 to 2017, Director of Rigi Healthcare AG, Chief Marketing Officer of Wyeth LLC, Executive Vice President-International of Biogen MA, Inc., Chief Operating Officer of Elan Corp.
Plc from 2012 to 2014, COO, EVP, Head-Global Neurology & International of Biogen, Inc. from 2001 to 2009, and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC from 1998 to 2001.
Mr. Hasler obtained an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-03-2023 8 641 ( 0.12% ) 2 M $ 31-03-2024
21-11-2023 5 500 000 ( 0.70% ) 140 690 $ 31-03-2024
23-06-2023 19 558 ( 0.12% ) 73 734 $ 31-03-2024
27-09-2023 1 250 ( 0.02% ) 3 225 $ 31-03-2024

Actieve functies van Hans-Peter Hasler

BedrijvenFunctieBegin
HBM HEALTHCARE INVESTMENTS AG Chairman 01-06-2009
MINERVA NEUROSCIENCES, INC. Director/Board Member 10-12-2017
SHIELD THERAPEUTICS PLC Chairman 18-06-2020
GAIN THERAPEUTICS, INC. Director/Board Member 01-01-2021
Founder 01-04-2016
Corporate Officer/Principal -
Medical Imaging Analysis Center Chairman 01-12-2012
Alle actieve functies van Hans-Peter Hasler

Eerdere bekende functies van Hans-Peter Hasler

BedrijvenFunctieEinde
DR. REDDY'S LABORATORIES LIMITED Director/Board Member 14-06-2018
PATHEON N.V. Director/Board Member 29-08-2017
░░░░ ░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ervaring van Hans-Peter Hasler in detail bekijken

Opleiding van Hans-Peter Hasler

Schweizerisches Institut für Betriebsökonomie AG Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hans-Peter Hasler in detail bekijken

Connecties

100 +

Eerstegraads connecties

28

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven6
BIOGEN INC.

Health Technology

DR. REDDY'S LABORATORIES LIMITED

Health Technology

SANTHERA PHARMACEUTICALS HOLDING AG

Health Technology

CELLTRION, INC.

Health Technology

MINERVA NEUROSCIENCES, INC.

Health Technology

SHIELD THERAPEUTICS PLC

Health Technology

Bedrijven in privébezit21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Wyeth Pharma GmbH

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Wyeth Pharmaceuticals AG

Canyon Pharmaceuticals AG

Health Technology

Wyeth-lederle Pharma GmbH

Health Technology

Health Technology

Medical Imaging Analysis Center

Commercial Services

Commercial Services

Rigi Healthcare AG

Gain Therapeutics, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Hans-Peter Hasler